Загрузка...
Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program
The DIAMOND study demonstrated that the addition of real-time continuous glucose monitoring (rtCGM) effectively lowers glycated hemoglobin (HbA(1c)) in patients with type 1 (T1D) and type 2 diabetes (T2D), treated with multiple daily injections (MDI). This post hoc analysis investigated whether DIAM...
Сохранить в:
| Опубликовано в: : | Diabetes Technol Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6080123/ https://ncbi.nlm.nih.gov/pubmed/30044123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0163 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|